about
Insights into the evolution of Yersinia pestis through whole-genome comparison with Yersinia pseudotuberculosisAn experimentally-supported genome-scale metabolic network reconstruction for Yersinia pestis CO92.Yersinia pestis in the Age of Big Data.Amino acid and structural variability of Yersinia pestis LcrV protein.Pleiotropic effects of the lpxM mutation in Yersinia pestis resulting in modification of the biosynthesis of major immunoreactive antigens.Functional characterization of Yersinia pestis aerobic glycerol metabolism.Molecular characterization of L-413C, a P2-related plague diagnostic bacteriophage.Russian vaccines against especially dangerous bacterial pathogens.Characterization of an F1 deletion mutant of Yersinia pestis CO92, pathogenic role of F1 antigen in bubonic and pneumonic plague, and evaluation of sensitivity and specificity of F1 antigen capture-based dipsticks.Further characterization of a highly attenuated Yersinia pestis CO92 mutant deleted for the genes encoding Braun lipoprotein and plasminogen activator protease in murine alveolar and primary human macrophages.Combinational deletion of three membrane protein-encoding genes highly attenuates yersinia pestis while retaining immunogenicity in a mouse model of pneumonic plague.CRP-Mediated Carbon Catabolite Regulation of Yersinia pestis Biofilm Formation Is Enhanced by the Carbon Storage Regulator Protein, CsrA.Expression and Association of the Yersinia pestis Translocon Proteins, YopB and YopD, Are Facilitated by Nanolipoprotein ParticlesNew Role for FDA-Approved Drugs in Combating Antibiotic-Resistant BacteriaDirect transcriptional control of the plasminogen activator gene of Yersinia pestis by the cyclic AMP receptor proteinA multi-omic systems approach to elucidating Yersinia virulence mechanisms.Braun lipoprotein (Lpp) contributes to virulence of yersiniae: potential role of Lpp in inducing bubonic and pneumonic plague.A Replication-Defective Human Type 5 Adenovirus-Based Trivalent Vaccine Confers Complete Protection against Plague in Mice and Nonhuman Primates.Evaluation of a Yersinia pestis mutant impaired in a thermoregulated type VI-like secretion system in flea, macrophage and murine models.New Insights into Autoinducer-2 Signaling as a Virulence Regulator in a Mouse Model of Pneumonic Plague.Plague vaccines: current developments and future perspectives.MPLEx: a method for simultaneous pathogen inactivation and extraction of samples for multi-omics profiling.Assessment of Live Plague Vaccine Candidates.Improved detection of Bartonella DNA in mammalian hosts and arthropod vectors by real-time PCR using the NADH dehydrogenase gamma subunit (nuoG).Tetraacylated lipopolysaccharide of Yersinia pestis can inhibit multiple Toll-like receptor-mediated signaling pathways in human dendritic cells.A Yersinia pestis lpxM-mutant live vaccine induces enhanced immunity against bubonic plague in mice and guinea pigs.Urogenital Chlamydia trachomatis multilocus sequence types and genovar distribution in chlamydia infected patients in a multi-ethnic region of Saratov, Russia.Phylogeny and Classification of Yersinia pestis Through the Lens of Strains From the Plague Foci of Commonwealth of Independent States.First Detection of Swedish' Variant (nvCT) in a Russian Couple with InfertilityBinding of LcrV protein from Yersinia pestis to human T-cells induces apoptosis, which is completely blocked by specific antibodiesMulti-locus sequence analysis reveals a novel sequence type of Chlamydia trachomatis in Saratov Region, RussiaNew Promising Targets for Synthetic Omptin-Based Peptide Vaccine against Gram-Negative Pathogens
P50
Q22066387-2C9A55B3-62D7-4B14-97B2-B7240A640C43Q31034683-112B2A4D-2753-42FF-98BA-60B7EB659F3EQ31135887-8D21BA86-084A-4C81-9E95-24A838E3CEC2Q33636983-47B20E5E-D587-4B2C-A01D-7607B094C43AQ34394184-9B5613EC-2097-4D2F-B077-B2A06EF24FC2Q34603220-0B1A1CAF-0749-4EE4-ABAD-D989B8DC4BBCQ34719420-E7ACA6EE-DB33-4B57-BC99-55F2826664E5Q35050833-702A14FF-EF96-4621-8BC8-8E8ED1B005D4Q35066593-E6923127-74E7-4B66-9ABC-0BAA11B68A2BQ35186608-13893CD2-E332-489E-817D-111175261BF6Q35187610-1F9D4C57-7650-43AF-840F-B970B0A7AA15Q35754659-6A99A8BC-D711-4A54-BCC6-67D20FE26101Q35970485-3600142E-948E-4BC5-80A3-FD71DF72DEE3Q35986316-6FB346C8-E08B-4A22-9DD0-5E100692E904Q36314655-98DB8DCD-5FB8-42C4-91B4-793F321A0057Q36456421-D5ABD23E-EC03-4DDE-A152-8DE8B35ACAE9Q36539626-B9AFA81F-4972-4FB5-B4FB-99CCB75E7324Q37067254-D03D99E7-13BB-4FCF-A1E6-982F41C2ADA6Q37399724-076BAE95-7E8B-4236-9488-472A142677AFQ37503760-ACFB9097-8541-4D07-94E5-D6665B5F951CQ38514208-23CBBF3C-7FC3-46F6-AE7F-28D159DE04C5Q38721171-89999736-C95F-46F3-8FC0-57134C0FFAA8Q40715711-16699733-7E3D-465A-A29C-6B9D5366FDBFQ41429061-F3B62A20-F9EF-4087-B590-947349A1945CQ41436938-D431FB96-B874-4953-B8DE-C299555D8DA8Q41446828-C85F7911-9AB6-4D4E-9754-EEFD3FCE35CAQ52594163-DCAC0A53-14A4-4DA2-B5DE-5761676895F4Q54943849-044C6936-7AFA-4ED8-82D2-A3909323CB3FQ59137579-AB95632F-C2A4-49FC-BE25-120107593556Q91462205-E8397452-CCEA-4A03-9124-5B0944657337Q92355992-54F91150-211A-4F56-8FCD-E99A2BDA2554Q93033597-79B271AD-A1D3-444D-A3D4-01642855ABB5
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Vladimir Motin
@en
Vladimir Motin
@nl
Wladimir Leonidowitsch Motin
@de
Владимир Леонидович Мотин
@ru
type
label
Vladimir Motin
@en
Vladimir Motin
@nl
Wladimir Leonidowitsch Motin
@de
Владимир Леонидович Мотин
@ru
altLabel
Vladimir L Motin
@en
Vladimir Leonidovich Motin
@en
Wladimir Motin
@de
prefLabel
Vladimir Motin
@en
Vladimir Motin
@nl
Wladimir Leonidowitsch Motin
@de
Владимир Леонидович Мотин
@ru
P106
P21
P31
P496
0000-0002-4762-457X